Profile for Effectiveness along with basic safety associated with once-daily single-inhaler triple treatment (FF/UMEC/VI) compared to FF/VI throughout patients together with improperly controlled asthma attack (Leader): any double-blind, randomised, stage 3A trial. (animebabies74)